Opeyemi Olabisi
@opeyemiolabisi.bsky.social
Physician-Scientist, Adult nephrologist. Passionately seeking prevention & cure for APOL1 kidney disease.
Pinned
Twice an Immigrant, Twice a Survivor: The Miraculous Life of a Nurse Who Could Not Be Stopped
Amazon.com: Twice an Immigrant, Twice a Survivor: The Miraculous Life of a Nurse Who Could Not Be Stopped: 9798287609443: Olabisi, Joshua, Onime, Godfrey: Books
www.amazon.com
I wasn’t born into wealth. I was born into the strength of Joshua Olabisi.
His life story—Twice an Immigrant, Twice a Survivor—is full of grit, grace, and divine turns.
Read it here: www.amazon.com/Twice-Immigr...
#Legacy #Resilience #TwiceASurvivor
My father’s story. My lifelong inspiration.
His life story—Twice an Immigrant, Twice a Survivor—is full of grit, grace, and divine turns.
Read it here: www.amazon.com/Twice-Immigr...
#Legacy #Resilience #TwiceASurvivor
My father’s story. My lifelong inspiration.
It was a pleasure to have Dr. Sanna-Cherchi @genetickidneydoc.bsky.social give an excellent, well-attended, Renal Grand Rounds at @dukekidney.bsky.social He is an embodiment of collaborative excellence💪🏾 @columbiakidney.bsky.social
August 18, 2025 at 2:08 PM
It was a pleasure to have Dr. Sanna-Cherchi @genetickidneydoc.bsky.social give an excellent, well-attended, Renal Grand Rounds at @dukekidney.bsky.social He is an embodiment of collaborative excellence💪🏾 @columbiakidney.bsky.social
I wasn’t born into wealth. I was born into the strength of Joshua Olabisi.
His life story—Twice an Immigrant, Twice a Survivor—is full of grit, grace, and divine turns.
Read it here: www.amazon.com/Twice-Immigr...
#Legacy #Resilience #TwiceASurvivor
My father’s story. My lifelong inspiration.
His life story—Twice an Immigrant, Twice a Survivor—is full of grit, grace, and divine turns.
Read it here: www.amazon.com/Twice-Immigr...
#Legacy #Resilience #TwiceASurvivor
My father’s story. My lifelong inspiration.
Twice an Immigrant, Twice a Survivor: The Miraculous Life of a Nurse Who Could Not Be Stopped
Amazon.com: Twice an Immigrant, Twice a Survivor: The Miraculous Life of a Nurse Who Could Not Be Stopped: 9798287609443: Olabisi, Joshua, Onime, Godfrey: Books
www.amazon.com
July 20, 2025 at 9:11 PM
I wasn’t born into wealth. I was born into the strength of Joshua Olabisi.
His life story—Twice an Immigrant, Twice a Survivor—is full of grit, grace, and divine turns.
Read it here: www.amazon.com/Twice-Immigr...
#Legacy #Resilience #TwiceASurvivor
My father’s story. My lifelong inspiration.
His life story—Twice an Immigrant, Twice a Survivor—is full of grit, grace, and divine turns.
Read it here: www.amazon.com/Twice-Immigr...
#Legacy #Resilience #TwiceASurvivor
My father’s story. My lifelong inspiration.
I am delighted to step into this exciting role. I look forward to advancing the clinical, research and educational missions of Duke Nephrology while supporting colleagues and inspiring learners!
We are excited to announce that Dr. Opeyemi Olabisi will be appointed as the next Chief of Nephrology in the Department of Medicine
medicine.duke.edu/ne...
medicine.duke.edu/ne...
May 16, 2025 at 1:10 AM
I am delighted to step into this exciting role. I look forward to advancing the clinical, research and educational missions of Duke Nephrology while supporting colleagues and inspiring learners!
Simone @genetickidneydoc.bsky.social is a visionary and alliance-building, result-oriented scientist. His #rFSGS biobank will help the whole community. Refer your rFSGS patients to his registry. Together, we can conquer the #rFSGS menace.
Our #rFSGS biobank is growing and we welcome patients from all over the world! Please reach out to us if you are a patient or a physician caring for one. We are creating a resource for everyone to use with the goal of resolving this disease and find new cures.
#KidneyMonth2025 #RareDisease #genetics
#KidneyMonth2025 #RareDisease #genetics
Building a biobank is key to finding new treatments for Recurrent Focal Segmental Glomerulosclerosis. If you or someone you know has #rFSGS and you want to learn how you can help by providing a biosample, email mb5150@cumc.columbia.edu.
#KidneyMonth #KidneyTransplant #nephsky #medsky #skyneph
#KidneyMonth #KidneyTransplant #nephsky #medsky #skyneph
March 22, 2025 at 2:17 PM
Simone @genetickidneydoc.bsky.social is a visionary and alliance-building, result-oriented scientist. His #rFSGS biobank will help the whole community. Refer your rFSGS patients to his registry. Together, we can conquer the #rFSGS menace.
Reposted by Opeyemi Olabisi
Our #rFSGS biobank is growing and we welcome patients from all over the world! Please reach out to us if you are a patient or a physician caring for one. We are creating a resource for everyone to use with the goal of resolving this disease and find new cures.
#KidneyMonth2025 #RareDisease #genetics
#KidneyMonth2025 #RareDisease #genetics
Building a biobank is key to finding new treatments for Recurrent Focal Segmental Glomerulosclerosis. If you or someone you know has #rFSGS and you want to learn how you can help by providing a biosample, email mb5150@cumc.columbia.edu.
#KidneyMonth #KidneyTransplant #nephsky #medsky #skyneph
#KidneyMonth #KidneyTransplant #nephsky #medsky #skyneph
March 18, 2025 at 5:33 PM
Our #rFSGS biobank is growing and we welcome patients from all over the world! Please reach out to us if you are a patient or a physician caring for one. We are creating a resource for everyone to use with the goal of resolving this disease and find new cures.
#KidneyMonth2025 #RareDisease #genetics
#KidneyMonth2025 #RareDisease #genetics
Reposted by Opeyemi Olabisi
Congratulations Dr. @opeyemiolabisi.bsky.social for being elected to the American Society for Clinical Investigation (ASCI)! @the-asci.bsky.social
medicine.duke.edu/news/two-duk...
medicine.duke.edu/news/two-duk...
Two Duke Nephrologists Elected to American Society for Clinical Investigation
Two Duke Department of Medicine faculty members, physician-scientists Opeyemi A. Olabisi, MD, PhD, and Tomokazu Souma, MD, PhD, are among the 2025 researchers elected to the American Society for Clini...
medicine.duke.edu
February 22, 2025 at 5:38 PM
Congratulations Dr. @opeyemiolabisi.bsky.social for being elected to the American Society for Clinical Investigation (ASCI)! @the-asci.bsky.social
medicine.duke.edu/news/two-duk...
medicine.duke.edu/news/two-duk...
Reposted by Opeyemi Olabisi
Congratulations to Dr. Tomasi @AleTomasiMD on being appointed as the chief nephrology fellow for the academic year 2025-2026.
February 16, 2025 at 3:05 PM
Congratulations to Dr. Tomasi @AleTomasiMD on being appointed as the chief nephrology fellow for the academic year 2025-2026.
Reposted by Opeyemi Olabisi
New from Dr Anika Lucas and colleagues in Kidney360
2nd Trimester Kidney Function and Adverse Pregnancy Outcomes among Patients with Lupus
journals.lww.com/kid...
2nd Trimester Kidney Function and Adverse Pregnancy Outcomes among Patients with Lupus
journals.lww.com/kid...
February 15, 2025 at 9:04 PM
New from Dr Anika Lucas and colleagues in Kidney360
2nd Trimester Kidney Function and Adverse Pregnancy Outcomes among Patients with Lupus
journals.lww.com/kid...
2nd Trimester Kidney Function and Adverse Pregnancy Outcomes among Patients with Lupus
journals.lww.com/kid...
Face-to-face interactions often facilitate collaboration and innovation. Therefore, @dukekidney.bsky.social research retreat focused on ways to increase purposeful interaction and collaboration. It was a time well spent!
we had a wonderful nephrology divisional research retreat at @ncbiotech this past Friday
January 26, 2025 at 4:35 PM
Face-to-face interactions often facilitate collaboration and innovation. Therefore, @dukekidney.bsky.social research retreat focused on ways to increase purposeful interaction and collaboration. It was a time well spent!
Reposted by Opeyemi Olabisi
Happy to share this excellent editorial on our recent NEJM paper www.nejm.org/doi/10.1056/... by Simone @genetickidneydoc.bsky.social Simone you nailed it! www.nejm.org/doi/10.1056/... 🙏🏽
APOL1 Kidney Disease Variants — Information from West Africa at Last | NEJM
Chronic kidney disease (CKD) has a devastating effect on populations of African ancestry
worldwide and disproportionately affects persons in West African countries,1 in whom
CKD, once present, ofte...
www.nejm.org
January 17, 2025 at 5:43 PM
Happy to share this excellent editorial on our recent NEJM paper www.nejm.org/doi/10.1056/... by Simone @genetickidneydoc.bsky.social Simone you nailed it! www.nejm.org/doi/10.1056/... 🙏🏽
I am delighted to be elected as a member of The American Society for Clinical Investigation! I’m thankful for my dedicated lab team, mentors, supportive family & colleagues @the-asci.bsky.social @dukekidney.bsky.social @dukemedschool.bsky.social
January 10, 2025 at 1:30 AM
I am delighted to be elected as a member of The American Society for Clinical Investigation! I’m thankful for my dedicated lab team, mentors, supportive family & colleagues @the-asci.bsky.social @dukekidney.bsky.social @dukemedschool.bsky.social
Reposted by Opeyemi Olabisi
😁 Delighted to have my copy of ‘The Body’s Keepers’📔personally signed by author, Dr. Paul Kimmel🖋️
. This📔offers both a historical perspective➕personal look at development of kidney failure treatments, highlighting advances along w/ ongoing challenges | #KidneyHealth | #Innovation 🏥
👉🏽 t.ly/7UuYT
. This📔offers both a historical perspective➕personal look at development of kidney failure treatments, highlighting advances along w/ ongoing challenges | #KidneyHealth | #Innovation 🏥
👉🏽 t.ly/7UuYT
January 6, 2025 at 1:11 AM
😁 Delighted to have my copy of ‘The Body’s Keepers’📔personally signed by author, Dr. Paul Kimmel🖋️
. This📔offers both a historical perspective➕personal look at development of kidney failure treatments, highlighting advances along w/ ongoing challenges | #KidneyHealth | #Innovation 🏥
👉🏽 t.ly/7UuYT
. This📔offers both a historical perspective➕personal look at development of kidney failure treatments, highlighting advances along w/ ongoing challenges | #KidneyHealth | #Innovation 🏥
👉🏽 t.ly/7UuYT
Reposted by Opeyemi Olabisi
Summer Undergraduate Program in Kidney Science (SUPerKS) provides talented students the unique opportunity to explore research and physician-scientist careers in the kidney field with exposure to the practice of medicine. hopkinsmedicine.org/nephrology/e... Applications due by February 1, 2025
Summer Undergraduate Program in Kidney Science (SUPerKS)
hopkinsmedicine.org
January 1, 2025 at 3:28 AM
Summer Undergraduate Program in Kidney Science (SUPerKS) provides talented students the unique opportunity to explore research and physician-scientist careers in the kidney field with exposure to the practice of medicine. hopkinsmedicine.org/nephrology/e... Applications due by February 1, 2025
Reposted by Opeyemi Olabisi
JCI - Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice www.jci.org/articles/vie...
JCI -
Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice
www.jci.org
December 18, 2024 at 2:15 PM
JCI - Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice www.jci.org/articles/vie...
Reposted by Opeyemi Olabisi
We featured Chideraa Emma-Ugwuoke an outstanding PRIME PUMP scholar in the Student Corner of the OPSD December Newsletter. He worked with @opeyemiolabisi.bsky.social. Click the link to learn more about Chideraa's summer research experience @dukemedschool.bsky.social.
mailchi.mp/duke/opsd-de...
mailchi.mp/duke/opsd-de...
December 19, 2024 at 8:28 PM
We featured Chideraa Emma-Ugwuoke an outstanding PRIME PUMP scholar in the Student Corner of the OPSD December Newsletter. He worked with @opeyemiolabisi.bsky.social. Click the link to learn more about Chideraa's summer research experience @dukemedschool.bsky.social.
mailchi.mp/duke/opsd-de...
mailchi.mp/duke/opsd-de...
Reposted by Opeyemi Olabisi
Hello there, #NephSky 🙂
Check out the December issue of KI!
Topics include:
🔹#AKI after hair straightening
🔹RAS inhibition attenuates #FSGS in mice with #APOL1 risk variants
🔹A dual #GLP-1 and glucagon receptor agonist in #diabetickidneydisease
🔗doi.org/10.1016/j.kint.2024.10.006
#MedSky
December 12, 2024 at 2:19 AM
Reposted by Opeyemi Olabisi
How did the #APOL1 protective variant arise on the G2 haplotype? My initial guess was by independent mutational event, but look at this: a close proximity recombination event between G0 and G2. Read this report from Martin Pollak team to which we contributed #FSGS
academic.oup.com/g3journal/ad...
academic.oup.com/g3journal/ad...
The APOL1 p.N264K variant is co-inherited with the G2 kidney disease risk variant through a proximity recombination event
Abstract. Black Americans are three to four times more likely to develop nondiabetic kidney disease than other populations. Exclusively found in people of
academic.oup.com
December 11, 2024 at 3:48 PM
How did the #APOL1 protective variant arise on the G2 haplotype? My initial guess was by independent mutational event, but look at this: a close proximity recombination event between G0 and G2. Read this report from Martin Pollak team to which we contributed #FSGS
academic.oup.com/g3journal/ad...
academic.oup.com/g3journal/ad...
What an inspiring conference!
Now, @opeyemiolabisi.bsky.social presenting about the role of kidney organoids in helping to study rFSGS @rfsgsinitiative.bsky.social @genetickidneydoc.bsky.social @gbadegesinlab.bsky.social
December 9, 2024 at 11:39 PM
What an inspiring conference!
Reposted by Opeyemi Olabisi
Reposted by Opeyemi Olabisi
Minus 10 days to the first ever, recurrent FSGS Conference!
Registration is open for a few more days!
Meet in person >60 patients/family members, Congressmen and Senators, and top scientists! ⬇️
@gbadegesinlab.bsky.social
@kidneyomicsamps.bsky.social @opeyemiolabisi.bsky.social
#rFSGS
#nephsky
Registration is open for a few more days!
Meet in person >60 patients/family members, Congressmen and Senators, and top scientists! ⬇️
@gbadegesinlab.bsky.social
@kidneyomicsamps.bsky.social @opeyemiolabisi.bsky.social
#rFSGS
#nephsky
You're in luck! It's not too late to register for the Recurrent Focal Segmental Glomerulosclerosis (rFSGS) Conference. Visit our website and submit your registration today to join us on Dec. 9: www.scgcorp.com/rFSGS2024/Re... #rFSGS #rFSGSConference
November 29, 2024 at 11:20 PM
Minus 10 days to the first ever, recurrent FSGS Conference!
Registration is open for a few more days!
Meet in person >60 patients/family members, Congressmen and Senators, and top scientists! ⬇️
@gbadegesinlab.bsky.social
@kidneyomicsamps.bsky.social @opeyemiolabisi.bsky.social
#rFSGS
#nephsky
Registration is open for a few more days!
Meet in person >60 patients/family members, Congressmen and Senators, and top scientists! ⬇️
@gbadegesinlab.bsky.social
@kidneyomicsamps.bsky.social @opeyemiolabisi.bsky.social
#rFSGS
#nephsky
@genetickidneydoc.bsky.social it was delightful working with you and your excellent team on this perspective.
Freshly published in JASN!
Read our perspective on #APOL1 kidney risk variants and their implications, based on the recent H3Africa publication in the NEJM
@opeyemiolabisi.bsky.social @gbadegesinlab.bsky.social
journals.lww.com/jasn/citatio...
www-nejm-org.ezproxy.cul.columbia.edu/doi/10.1056/...
Read our perspective on #APOL1 kidney risk variants and their implications, based on the recent H3Africa publication in the NEJM
@opeyemiolabisi.bsky.social @gbadegesinlab.bsky.social
journals.lww.com/jasn/citatio...
www-nejm-org.ezproxy.cul.columbia.edu/doi/10.1056/...
Prevalence and Impact of APOL1 Kidney Risk Variants in West ... : Journal of the American Society of Nephrology
An abstract is unavailable. This article is available as a PDF only.
journals.lww.com
November 29, 2024 at 2:40 AM
@genetickidneydoc.bsky.social it was delightful working with you and your excellent team on this perspective.
Reposted by Opeyemi Olabisi
The final version of our paper www.nejm.org/doi/10.1056/... One APOL1 risk variant is associated with CKD & FSGS. We have a solid basis for new mechanistic studies in our journey to find durable cure for APOL1 KD @opeyemiolabisi.bsky.social @kidneyomicsamps.bsky.social @genetickidneydoc.bsky.social
November 23, 2024 at 9:11 PM
The final version of our paper www.nejm.org/doi/10.1056/... One APOL1 risk variant is associated with CKD & FSGS. We have a solid basis for new mechanistic studies in our journey to find durable cure for APOL1 KD @opeyemiolabisi.bsky.social @kidneyomicsamps.bsky.social @genetickidneydoc.bsky.social
Are your patients with APOL1 kidney disease on optimal doses of ACEi/ARB? See my new commentary on an interesting mouse-based study from Pollak lab #APOL1 @genetickidneydoc.bsky.social @nephrosparks.bsky.social @kidneyomicsamps.bsky.social @gbadegesinlab.bsky.social @dukekidney.bsky.social
November 22, 2024 at 4:02 PM
Are your patients with APOL1 kidney disease on optimal doses of ACEi/ARB? See my new commentary on an interesting mouse-based study from Pollak lab #APOL1 @genetickidneydoc.bsky.social @nephrosparks.bsky.social @kidneyomicsamps.bsky.social @gbadegesinlab.bsky.social @dukekidney.bsky.social